COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,568,600 | -36.8% | 6,380,000 | +2.1% | 0.03% | -34.9% |
| Q2 2023 | $19,875,000 | -2.8% | 6,250,000 | 0.0% | 0.04% | -6.5% |
| Q1 2023 | $20,437,500 | -29.6% | 6,250,000 | +8.2% | 0.05% | -33.3% |
| Q4 2022 | $29,047,244 | +176.6% | 5,774,800 | +25.4% | 0.07% | +165.4% |
| Q3 2022 | $10,503,000 | -10.1% | 4,606,600 | +4.5% | 0.03% | -3.7% |
| Q2 2022 | $11,677,000 | +274.4% | 4,406,600 | +93.5% | 0.03% | +350.0% |
| Q1 2022 | $3,119,000 | -29.7% | 2,277,000 | +62.6% | 0.01% | -25.0% |
| Q4 2021 | $4,438,000 | – | 1,400,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |